Healthcare Stocks Hit A Speed Bump, but most TECH Stocks Roll On
Dow (DIA) is Down 2.3% month to date The XLV was down 2.52% to $167 reflecting the weighting of large cap biophrarma drugs in the ETF, the IBB was down 2.17% to the $207 level. The XLK was up only 0.32% but other tech sectors did better but volatile; SMH up 1.19%.,NVDA down 2%, AMD and DELL...
Choppy Markets Ahead as We Wait for Q3 Earnings and a Grim September…Update-2…sector watch
Update-29/10/26…3 P EDT,….interest rates increase with PPI up 0.4%, ECB rate hike,XLB off 4% for wk hits silver and gold stocks. OIL tops $100 as equities in orderly sell-off. NVDA down, APPLE up Update-1 ..9/5/26…Stay with the following sectors for trades: Technology,...
Sector Watch: Now Biotech and Healthcare has the Momentum as Rotation Continues–Update-3 8/29
Update-3,,,,8/29/26….Despite some big news this week, healthcare and biotech stocks reversed and sold off from the 2026 top. Revolution Medicine (RVMD) sold off 6% from its daily trading high on the news that the FDA approved its targeted therapy for pancreatic cancer RASONQUE. In the...
Large Cap Biopharma Boosts Portfolio Gains…Update-2 8/21/26 Green screen day
8/21/26…Another big day for biotech makes me want to review my SMID Biotech Focus list in depth as many of our stocks are near YTD highs and both the IBB and XBI are within 2% of highs so a week-end of digestion could be good. Despite the WAR and issues in the bond market equities still...
Healthcare Sector Strategies: You Need a Little Biotech! Update-2…8/18 SMID biotechs soar
Update-2 …8/18/26. ….SMID Biotechs soar: Top PIck Xencor (XNCR) up 9.9% on improved P&L, more news on the way.. BridgeBio Pharma up 3.87% on financing, oversubscribed. SCRIBE (SCTX) surges 25% on analyst initiations; Gene editing drug for cardiology. Update-1...